Markets › United States › NAS › MOLN

Molecular Partners AG

NAS:MOLNHealthcarenasdaq_composite

$3.70+1.09%LiveIn session · ≈ AED 13.59 · Market cap $153.48M · Next earnings Thu 29 Oct

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	−500.1%	−497.2%	73.2%	−579.8%	−855.8%	—	—	—
Operating margin	−624.2%	−679.7%	61.5%	−868.3%	−1,231.7%	—	—	—
Net margin	−671.7%	−683.7%	62.2%	−880.7%	−1,087.4%	—	—	—
EBITDA margin	−637.7%	−650.2%	62.8%	−845.6%	−1,039.2%	—	—	—
Return on equity	−58.5%	−59.5%	50.1%	−35.1%	−38.2%	−76.7%	−76.7%	+0.0 pts
Return on assets	−33.5%	−36.9%	44.9%	−31.2%	−34.1%	−60.4%	−60.4%	+0.0 pts
Return on capital employed	−44.9%	−50.4%	47.6%	−33.2%	−41.4%	−63.8%	—	—
Debt / equity	0.1×	0.1×	0.0×	0.0×	0.0×	0.0×	0.0×	+0.0%
Debt / assets	3.8%	3.5%	1.8%	1.8%	1.5%	3.6%	—	—
Interest coverage	−180.1×	−104.3×	179.9×	−1,247.1×	−2,448.7×	−3,229.1×	—	—
Current ratio	3.1×	3.5×	14.8×	13.4×	14.3×	8.8×	8.8×	+0.0%
Quick ratio	3.1×	3.5×	14.8×	13.4×	14.3×	8.8×	—	—
Cash ratio	2.3×	1.5×	5.1×	4.7×	5.9×	7.5×	7.5×	+0.0%
Asset turnover	0.0×	0.1×	0.7×	0.0×	0.0×	0.0×	—	—
Inventory turnover	−281.8×	27,859,000.0×	—	—	—	—	—	—
Receivables turnover	3.3×	0.4×	111.6×	4.0×	17.4×	0.0×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—